Sign in

NCT03570021Active, not recruitingPhase 3

ESTIMation of the ABiLity of Prophylactic Central Compartment Neck Dissection to Modify Outcomes in Low-risk Differentiated Thyroid Cancer

Source: ClinicalTrials.gov · Last updated 6 Mar 2026

Brief summary (registry, in English)

Prospective randomized open phase III non-inferiority trial in cT1bT2N0 papillary thyroid carcinoma comparing: total thyroidectomy alone (experimental group) versus total thyroidectomy + Prophylactic Neck Dissection PND (reference group). Pre-registered patients will be randomized before surgery for tumors with class-6 cytology (Bethesda) or in the operating room after confirmation of malignancy by frozen section analysis for tumors with class-5 cytology.

Status (registry)
Active, not recruiting
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
352 (actual)
First submitted
15 Jun 2018
Start date
8 Aug 2018
Primary completion date
Dec 2026
Lead sponsor
Gustave Roussy, Cancer Campus, Grand Paris
NCT number
NCT03570021

What you commit to

  • Study type: Interventional · Phase 3
  • Participants enrolled: 352
  • From 8 Aug 2018 to the primary completion date, Dec 2026
  • 21 sites in 3 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Metastatic neck lymph nodes or suspicious neck nodes on pre- operative ultrasound (cN1); for suspicious nodes, FNAB cytology and thyroglobulin assay on the needle washout fluid will be performed

Lab values

  • Medullary thyroid carcinoma on FNAB cytology and/or with basal serum calcitonin \>50 pg/ml
  • Recurrent nerve paralysis visualized on systematic pre-operative laryngoscopy and/or abnormal preoperative serum calcium

Other

  • Tumors \> 40 mm (cT3) or ≤ 10 mm
  • Tumors with extrathyroidal extension suspected or obvious on the pre-operative work-up or intra-operatively (cT3T4)
  • Metastatic neck lymph nodes found during the thyroidectomy and confirmed with intra-operative frozen section analysis
  • Preoperative or intra-operative suspicion of non-papillary thyroid carcinoma or aggressive histopathological subtype or poorly differentiated carcinoma
  • Distant metastases (M1) apparent pre-operatively (found due to symptoms or fortuitously; no specific pre-operative work-up will be performed, however, in accordance with current clinical practice)
  • Pregnant or breast feeding women
  • Participation in another therapeutic clinical trial within one year from study entry
  • Patient under guardianship or deprived of his liberty by a judicial or administrative decision or incapable of giving its consent

Who the study is looking for

  • Thyroid nodule measuring 11-40 mm on ultrasound (cT1bT2)
    • AND with fine-needle aspiration biopsy (FNAB) cytology in favor of "papillary thyroid carcinoma" (Type 6 according to the Bethesda classification (or BRAF mutation found on cytology analysis) (Appendix 2)
    • OR with FNAB cytology "suspicious for malignancy" (Type 5 according to the Bethesda classification). In this latter case, randomization will be performed if confirmation of papillary carcinoma on intraoperative frozen section analysis
  • cN0: absence of lymph nodes suspicious for malignancy on pre- operative ultrasound performed by the center's designated radiologist according to a standardized report
  • Absence of a medical contra indication to performing a total thyroidectomy with or without bilateral prophylactic neck dissection of the central compartment
  • Women of childbearing potential should have a negative pregnancy test (serum or urine) before any radioiodine administration. Sexually active patients must agree to use an effective method of contraception or to abstain from sexual activity during the study and for at least 6 months after last dose of radioiodine.
  • Patient affiliated to a social security regimen or beneficiary of such regimen
  • Patients age ≥ 18 years old, french-speaking
  • Patients should understand, sign and date the written informed consent form prior to any protocol specific procedures. Patients should be able and willing to comply with study visits.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (21)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
CHU d Angers
Coordinator of this site? Confirm its status
AngersFranceUnknown status
Institut Bergonie
Coordinator of this site? Confirm its status
BordeauxFranceUnknown status
Hôpital Saint-André
Coordinator of this site? Confirm its status
BordeauxFranceUnknown status
Groupement Hospitalier Est
Coordinator of this site? Confirm its status
BronFranceUnknown status
Centre François Baclesse
Coordinator of this site? Confirm its status
CaenFranceUnknown status
Jean Perrin
Coordinator of this site? Confirm its status
Clermont-FerrandFranceUnknown status
Centre Georges François Leclerc
Coordinator of this site? Confirm its status
DijonFranceUnknown status
CH de Haguenau
Coordinator of this site? Confirm its status
HaguenauFranceUnknown status
CHU Lille - Hôpital Claude Huriez
Coordinator of this site? Confirm its status
LilleFranceUnknown status
CHU Nîmes
Coordinator of this site? Confirm its status
NîmesFranceUnknown status
CHU de Poitiers
Coordinator of this site? Confirm its status
PoitiersFranceUnknown status
Institut Godinot
Coordinator of this site? Confirm its status
ReimsFranceUnknown status
CHU Reims Hopital Robert Debre
Coordinator of this site? Confirm its status
ReimsFranceUnknown status
Centre Henri Becquerel
Coordinator of this site? Confirm its status
RouenFranceUnknown status
Institut De Cancerologie Strasbourg
Coordinator of this site? Confirm its status
StrasbourgFranceUnknown status
Institut Claudius Regaud
Coordinator of this site? Confirm its status
ToulouseFranceUnknown status
CHU de Toulouse - Hopital Larrey
Coordinator of this site? Confirm its status
ToulouseFranceUnknown status
CHRU Nancy - Hôpitaux de Brabois
Coordinator of this site? Confirm its status
Vandœuvre-lès-NancyFranceUnknown status
Gustave Roussy
Coordinator of this site? Confirm its status
VillejuifFranceUnknown status
CHU de Pointe à Pitre
Coordinator of this site? Confirm its status
Les AbymesGuadeloupeUnknown status
Clinique Saint Vincent
Coordinator of this site? Confirm its status
RéunionRéunionUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.